Clinical Trial Update: Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo [Phase 1]

View source ↗

Summary

Phase I randomized, placebo-controlled study in healthy male volunteers to evaluate safety, tolerability, and pharmacokinetics of QGC001 compared with placebo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• QGC001

Snippet

Sponsor: Quantum Genomics SA | Conditions: Essential Hypertension | Phase 1 | Status: COMPLETED